3N
3i Nanotech develops a point-of-care platform that utilizes advanced detection methods to monitor protein biomarkers in human samples. This technology enables rapid and accurate diagnostics, facilitating timely medical decisions in various healthcare settings.
Updated 20 months ago
Funding
$224.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NS
Funding rounds are not available yet.
Founders
Product
Features
- 3i Nanotech develops a point-of-care platform that utilizes advanced detection methods to monitor protein biomarkers in human samples. This technology enables rapid and accurate diagnostics, facilitating timely medical decisions in various healthcare settings.